Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Other(2)

Detailed Status

unknown2

Completed1

Active, not recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed120%

active_not_recruiting120%

terminated120%

unknown240%

Recent Activity

1 active trials

Showing 5 of 5

active_not_recruitingnot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT05990582Not Applicable

The Alkmaar MLPTI Cohort Study: Outcomes at 9 Years

Active Not Recruiting

NCT02913690Not Applicable

Palm Tocotrienols in Chronic Hemodialysis (Malaysia) (PATCH)

Unknown

NCT04062773Not Applicable

Time-Restricted Feeding on Glucose Homeostasis and Quality of Life

Unknown

NCT03590158Not Applicable

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID)

Completed

NCT03278236Not Applicable

Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?

Terminated

All 5 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 5